These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24307545)

  • 1. Module assembly for designing multivalent mid-sized inhibitors of protein-protein interactions.
    Ohkanda J
    Chem Rec; 2013 Dec; 13(6):561-75. PubMed ID: 24307545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalent inhibitors for disrupting protein surface-substrate interactions and for dual inhibition of protein prenyltransferases.
    Machida S; Kato N; Harada K; Ohkanda J
    J Am Chem Soc; 2011 Feb; 133(4):958-63. PubMed ID: 21158442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrimers as size selective inhibitors to protein-protein binding.
    Chiba F; Hu TC; Twyman LJ; Wagstaff M
    Chem Commun (Camb); 2008 Sep; (36):4351-3. PubMed ID: 18802567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Module assembly for protein-surface recognition: geranylgeranyltransferase I bivalent inhibitors for simultaneous targeting of interior and exterior protein surfaces.
    Machida S; Usuba K; Blaskovich MA; Yano A; Harada K; Sebti SM; Kato N; Ohkanda J
    Chemistry; 2008; 14(5):1392-401. PubMed ID: 18200641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of an organometallic glutathione transferase inhibitor.
    Ang WH; Parker LJ; De Luca A; Juillerat-Jeanneret L; Morton CJ; Lo Bello M; Parker MW; Dyson PJ
    Angew Chem Int Ed Engl; 2009; 48(21):3854-7. PubMed ID: 19396894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protein-protein interactions using designed molecules.
    Wilson AJ
    Chem Soc Rev; 2009 Dec; 38(12):3289-300. PubMed ID: 20449049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization and inhibition of protein-protein interactions: the 14-3-3 case study.
    Milroy LG; Brunsveld L; Ottmann C
    ACS Chem Biol; 2013 Jan; 8(1):27-35. PubMed ID: 23210482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface.
    Bier D; Bartel M; Sies K; Halbach S; Higuchi Y; Haranosono Y; Brummer T; Kato N; Ottmann C
    ChemMedChem; 2016 Apr; 11(8):911-8. PubMed ID: 26644359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of multimetallic dendrimers through non-covalent interactions.
    Snelders DJ; Virboul MA; Kreiter R; Versluis C; van Koten G; Klein Gebbink RJ
    Dalton Trans; 2012 Feb; 41(8):2354-9. PubMed ID: 22183187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of α-helix-mediated protein-protein interactions using designed molecules.
    Azzarito V; Long K; Murphy NS; Wilson AJ
    Nat Chem; 2013 Mar; 5(3):161-73. PubMed ID: 23422557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular Generation of a Diterpene-Peptide Conjugate that Inhibits 14-3-3-Mediated Interactions.
    Parvatkar P; Kato N; Uesugi M; Sato S; Ohkanda J
    J Am Chem Soc; 2015 Dec; 137(50):15624-7. PubMed ID: 26632868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
    Ma DL; Chan DS; Leung CH
    Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Thermoplasma acidophilum factor F3 mimics human aminopeptidase N (APN) as a target for anticancer drug development.
    Su J; Wang Q; Feng J; Zhang C; Zhu D; Wei T; Xu W; Gu L
    Bioorg Med Chem; 2011 May; 19(9):2991-6. PubMed ID: 21493078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schiff base transition metal complexes as novel inhibitors of xanthine oxidase.
    You ZL; Shi DH; Xu C; Zhang Q; Zhu HL
    Eur J Med Chem; 2008 Apr; 43(4):862-71. PubMed ID: 17706325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloform-selective inhibition: synthesis and structure-activity analysis of Mn(II)-form-selective inhibitors of Escherichia coli methionine aminopeptidase.
    Huang QQ; Huang M; Nan FJ; Ye QZ
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5386-91. PubMed ID: 16219464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid access to unexplored chemical space by ligand scanning around a ruthenium center: discovery of potent and selective protein kinase inhibitors.
    Bregman H; Carroll PJ; Meggers E
    J Am Chem Soc; 2006 Jan; 128(3):877-84. PubMed ID: 16417378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilizer-Guided Inhibition of Protein-Protein Interactions.
    Milroy LG; Bartel M; Henen MA; Leysen S; Adriaans JM; Brunsveld L; Landrieu I; Ottmann C
    Angew Chem Int Ed Engl; 2015 Dec; 54(52):15720-4. PubMed ID: 26537010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidomimetic modification improves cell permeation of bivalent farnesyltransferase inhibitors.
    Machida S; Tsubamoto M; Kato N; Harada K; Ohkanda J
    Bioorg Med Chem; 2013 Jul; 21(14):4004-10. PubMed ID: 23107667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
    Guo W; Wisniewski JA; Ji H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.